200 related articles for article (PubMed ID: 15237056)
1. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.
Gyarmathy VA; Rácz J; Neaigus A; Ujhelyi E
AIDS Educ Prev; 2004 Jun; 16(3):276-87. PubMed ID: 15237056
[TBL] [Abstract][Full Text] [Related]
2. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
3. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
4. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia.
Winstock AR; Anderson CM; Sheridan J
Med J Aust; 2006 Jun; 184(11):560-2. PubMed ID: 16768662
[TBL] [Abstract][Full Text] [Related]
5. [Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) testing among injecting drug users].
Gyarmathy VA; Rácz J
Orv Hetil; 2011 Jan; 152(4):124-30. PubMed ID: 21224188
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology of hepatitis C and human immunodeficiency virus infections among injecting drug users in Hungary--what's next?].
Gyarmathy VA; Rácz J
Orv Hetil; 2010 Mar; 151(10):365-71. PubMed ID: 20178967
[TBL] [Abstract][Full Text] [Related]
7. Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
Strauss SM; Astone JM; Des Jarlais DC; Hagan H
AIDS Patient Care STDS; 2005 Feb; 19(2):78-88. PubMed ID: 15716639
[TBL] [Abstract][Full Text] [Related]
8. Predictors of HIV and hepatitis testing and related service utilization among individuals with serious mental illness.
Goldberg RW; Himelhoch S; Kreyenbuhl J; Dickerson FB; Hackman A; Fang LJ; Brown CH; Wohlheiter KA; Dixon LB
Psychosomatics; 2005; 46(6):573-7. PubMed ID: 16288138
[TBL] [Abstract][Full Text] [Related]
9. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.
Rothman J; Rudnick D; Slifer M; Agins B; Heiner K; Birkhead G
J Urban Health; 2007 Mar; 84(2):226-42. PubMed ID: 17216572
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
Bini EJ; Kritz S; Brown LS; Robinson J; Calsyn D; Alderson D; Tracy K; McAuliffe P; Smith C; Rotrosen J
J Subst Abuse Treat; 2012 Jun; 42(4):438-45. PubMed ID: 22035702
[TBL] [Abstract][Full Text] [Related]
11. HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates.
Stopka TJ; Marshall C; Bluthenthal RN; Webb DS; Truax SR
Public Health Rep; 2007; 122 Suppl 2(Suppl 2):68-73. PubMed ID: 17542457
[TBL] [Abstract][Full Text] [Related]
12. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
Edlin BR; Kresina TF; Raymond DB; Carden MR; Gourevitch MN; Rich JD; Cheever LW; Cargill VA
Clin Infect Dis; 2005 Apr; 40 Suppl 5(Suppl 5):S276-85. PubMed ID: 15768335
[TBL] [Abstract][Full Text] [Related]
13. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C in the context of HIV disease: implications for incarcerated populations.
Spaulding AC; Lally M; Rich JD; Dieterich DT
AIDS Read; 1999 Oct; 9(7):481-91. PubMed ID: 12737140
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
Fuglsang T; Fouchard JR; Ege PP
Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
[TBL] [Abstract][Full Text] [Related]
16. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
17. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
Kresina TF; Bruce RD; Cargill VA; Cheever LW
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
[TBL] [Abstract][Full Text] [Related]
18. The BASHH HIV Special Interest Group (SIG).
Waters L; Edwards S
Sex Transm Infect; 2015 Feb; 91(1):6. PubMed ID: 25609464
[No Abstract] [Full Text] [Related]
19. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
20. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
